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ÖZET
Amaç:  Atriyoventriküler  nodal  re-entrant  taşikardilerin 
(AVNRT) radyo-frekans (RF) ablasyon tedavisi ile ilgili 
olarak klinik deneyimimizi, gözlenen komplikasyonları ve 
uzun dönem sonuçları kapsamlı bir şekilde değerlendir-
meyi amaçladık.
Gereç ve yöntem: Çalışmaya Hastane-1 (n=52) ve Has-
tane-2`de (n=114) olmak üzere toplam 166 AVNRT has-
tası alınmıştır. Bu hastalara temel elektrofizyolojiden son-
ra RF ablasyon tedavisi uygulanmıştır. işlem esnasında 
gözlenen komplikasyonlar ve uzun dönem takipte gelişen 
tekrarlamalar kaydedilmiştir.
Bulgular: Çalışmaya alınan hastaların >%90 da semp-
tomlar bir yıldan fazla devam etmekteydi ve en az 2 atak 
yaşamaktaydı. Tüm grup için RF ablasyon başarı oranı 
%98,2 idi. Tüm popülasyon için rekürrens oranı % 3 (5 
hasta) idi. AVNRT ablasyonu sonrası uzun dönem takip-
te rekürrens prediktorleri olarak yaş, operatör deneyimi 
(hastane 1 ve 2) ve atipik AVNRT varlığı olarak bulundu. 
AVNRT ablasyonu ile ilişkili majör komplikasyon oranı ol-
dukça düşük olup sadece 2 hastada derin ven trombo-
zu izlenirken, hiç bir hastada ölüm, miyokard enfarktüsü, 
inme veya kardiyak tamponad izlenmedi. Minor kompli-
kasyonlardan  asemptomatik  minimal-hafif  perikardiyal 
efüzyon 5 hastada, kasık yerinde transfüzyon gerektirme-
yen hematom (5 hasta) ve geçici AV blok (5 hasta) olarak 
tespit edildi. Sadece 1 hastada (% 0. 6) kalıcı pil implan-
tasyonu gerektiren AV blok izlendi.
Sonuç: AVNRT  nin  RF  ablasyonu  hem  akut  dönemde 
hemde uzun dönem takipte güvenli ve etkili bir yöntemdir. 
Atipik AVNRT varlığı, genç yaş ve operatör deneyimi uzun 
dönem rekürrens için esas belirleyicilerdir.
Anahtar kelimeler: Atriyoventriküler nodal re-entrant ta-
şikardi, Radyofrekans ablasyon, rekürrens, komplikasyon
ABSTRACT
Objectives: In this study, we aimed to evaluate our clini-
cal experience about the catheter ablation of atrioven-
tricular  nodal  reentrant  tachycardia  (AVNRT)  including 
complications and long-term outcomes.
Materials and Methods: The study population consisted 
of 166 patients with AVNRT, 52 of whom from hospital-1 
and 114 of who from hospital-2. Radio-frequency (RF) 
ablation therapy was applied after the basic electrophysi-
ology study. Complications in RF ablation and long-term 
recurrences were noted.
Results: More than 90% of the patients had symptoms 
persisting for more than one year and again more than 
90% of those were suffering at least 2 episodes per month. 
The success rate of RF ablation was 98.2% for the entire 
study population. The recurrence rate was observed to 
be 3% (n=5) throughout the follow-up period. In the mul-
tivariate Cox regression analysis; young age, operator`s 
experience (Hospital 1 vs. 2), and presence of atypical 
AVNRT were the independent predictors of long-term re-
currence. Major complications related to AVNRT ablation 
are not encountered frequently. Death, myocardial infarc-
tion and stroke were not seen in any of the patients, how-
ever, two patients developed deep vein thrombosis. Minor 
complications in RF ablation included asymptomatic mini-
mal/mild pericardial effusion (n=5), femoral hematoma re-
quiring no transfusion (n=5) and transient AV block (n=5). 
Atrio-ventricular  block  requiring  permanent  pacemaker 
implantation was found only in one patient (0.6%).
Conclusion:  Radio-frequency  catheter  ablation  in  pa-
tients  with AVNRT  appears  to  be  a  safe  and  effective 
method. The presence of atypical AVNRT, young age and 
operator`s experience were observed to be the indepen-
dent predictors of long-term recurrence.
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INTRODUCTION
Atrioventricular  nodal  reentrant  tachycardia 
(AVNRT) is the most common type of paroxysmal 
supraventricular tachycardia. Catheter ablation has 
become the first choice of curative treatment for 
symptomatic paroxysmal supraventricular arrhyth-
mia.1-3 Slow pathway ablation has high short-term 
and long-term success rates 3,4 with acceptable rates 
of complication.5 The radio-frequency (RF) ablation 
technique has produced a high acute success rate in 
patients with AVNRT and the risk for complete AV 
block has been less than 1%. However, recurrences 
after slow pathway ablation have been reported to 
vary widely and determinants of AVNRT recurrence 
after radiofrequency are largely unknown.3-5 In this 
two-center study, we aimed to evaluate our clinical 
experience about the catheter ablation of AVNRT 
cases  including  its  complications  and  long-term 
outcomes.
MATERIALS AND METHODS
Study Population
This prospective and two-center study included 166 
patients who were scheduled to receive RF ablation 
for AVNRT  in  two  hospitals  (Hospital-1,  52  pa-
tients; Hospital-2, 114 patients) in between January 
2007 - January 2011. Electrophysiology study and 
ablation procedures were performed by two opera-
tors (IHT, SS). First operator was junior and had a 
6-month  basic  electrophysiology  training  (Hospi-
tal-1), whereas the second operator was conversant 
with an experience of >50 cases/year (Hospital-2).
Prior  to  the  ablation  procedure,  information 
concerning the clinical data, currently used drugs, 
atherosclerotic risk factors, presence of coronary ar-
tery disease, echocardiography before RF ablation, 
12-channel ECGs, and/or ECGs showing tachycar-
dia, were recorded. Following the ablation, 24-hour 
heart rhythm monitoring was provided, and echo-
cardiography and 12-channel ECG were obtained 
again at 24 hours. Following RF ablation, the pa-
tients were called for follow-up visits at 1 week, 
1 month, and 6 months after the procedure during 
which  they  received  symptomatic  evaluation  and 
12-channel ECG test along with a 24-hour Holter 
recording in some required cases.
Our  study  was  approved  by  the  local  ethics 
committee.
Electrophysiology study
Electrophysiology study (EPS) was performed by 
using  3  catheters  inserted  via  femoral  vein:  two 
quadripolar catheters into the right ventricle and the 
His bundle region, a decapolar catheter into the cor-
onary sinus. The drugs used prior to the EPS were 
discontinued for at least 5 drug half-lives before the 
procedure. Following the basic electrophysiologic 
measurements (AH and HV intervals, PR intervals), 
AVNRT induction was attempted by the predeter-
mined protocols.6 In case of need, intravenous atro-
pine was administered. A decline of 10 ms in extra-
stimulus or a jump of >50 ms in A2H2 interval, in-
dicates dual atrioventricular (AV) nodal physiology.
Radio-frequency ablation procedure
Slow pathway ablation was performed with a 4 mm 
tip electrode ablation catheter in all the patients. RF 
ablation procedure was applied by using the previ-
ously described mapping and ablation techniques.6 
RF energy was delivered to elevate the heat up to 
50°C - 65°C. By carefully examining the intracardi-
ac electrogram and fluoroscopy recordings, RF en-
ergy was applied over the appropriate sites for 30s 
- 2 min. RF energy delivery was discontinued when 
the following conditions were observed: rapid junc-
tional tachycardia (JT) (with cycle length under 350 
ms), ventriculoatrial (VA) block or AV block, exces-
sive impedance elevation, and absence of junctional 
rhythm within the first 10 seconds. RF ablation was 
carried out via femoral vein in an antegrade fashion 
through the posteroseptal region of the tricuspid an-
nulus. The success of RF ablation was defined as 
detection of no more than a single echo beat and 
no inducible AVNRT during the electrophysiology 
studies performed 30 minutes after the RF ablation. 
In cases where there were more than one echo beats, 
the RF energy delivery was repeated.
Follow-up and complications
The patients were followed-up for a period of 6 to 
40 months. During the follow-up, the patients with a 
symptomatic palpitation episode were evaluated for 
recurrence. An ECG record showing tachycardia or 
induction of AVNRT in the repeat EPS, was recog-
nized as recurrence. Major complications were as 
follows: death, myocardial infarction (MI), stroke, 
severe  valvular  pathology,  pulmonary  embolism, 
deep vein thrombosis (DVT), cardiac tamponade, İ. H. Tanboğa et al. Ablation of atrioventricular nodal re-entrant tachycardia 168
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and  permanent  heart  block.  Minor  complications 
were pericardial effusion, temporary AV block, he-
matoma over the inguinal region, and AV fistula or 
pseudoaneurysm.
Statistical analysis
Continuous variables are expressed as mean (SD) 
or median (interquartile range) as which appropri-
ate. The level of significance was 0.05. To compare 
parametric  continuous  variables,  the  Independent 
Student t test or the Mann-Whitney U test were used. 
For categorical variables, the chi-square test was 
used. Recurrence rate during the follow-ups after 
AVNRT ablation was carried out with Kaplan-Mei-
er analysis, and the difference between groups with 
and without recurrence was analyzed by log-rank 
test. In order to determine the predictors of recur-
rence in univariate and multivariate analyses, Cox 
regression analysis was used after the verification of 
proportional hazards assumption (the variables with 
p<0.20 were included in the multivariate analysis). 
Statistical analyses were carried out by SPSS 15.0 
(Statistical Package for Social Science - SPSS, Inc., 
Chicago, Illinois, USA) package program.
RESULTS
The study population consisted of 166 AVNRT pa-
tients (RF ablation was applied on 52 patients in 
Hospital-1 and 114 patients in Hospital-2). The ba-
sic clinical characteristics of the study population 
are shown in table 1. More than 90% of the patients 
had symptoms persisting for more than a year and 
more than 90% of those were suffering at least 2 
episodes per month. Overall, 80% of the patients 
were on at least 1 antiarrhythmic agent. Among the 
antiarrhythmic agents, digoxin (n=11) and sotalol 
(n=3) were remarkable. One of our patients with 
history of paroxysmal atrial fibrillation attacks was 
on amiodarone.
The basic electrophysiologic characteristics of 
our study group are shown in Table 1. In basic EPS, 
54.2% of the patients demonstrated a jump. Sev-
en of those patients were diagnosed with atypical 
AVNRT. During the ablation, 98.8% of the patients 
exhibited  JT,  whereas  5.6%  displayed  VA  block. 
There was no difference between the PR intervals 
before and after the ablation. Overall RF ablation 
success rate was 98.2% (Table 2).
Table 1. Basic clinical characteristics of the study group
Age (year, mean ± SD) 47±18
Gender (male %) 31.9
Diabetes mellitus (%) 10.8
Hypertension (%) 24.7
Smoking (%) 30.7
Duration of symptoms (year, median) 6
An ECG showing tachycardia (%) 89.1
Symptom frequency (number
 of episodes/month, median)
2
Used antiarrhythmic drugs (%) 80
Metoprolol 40
Atenolol 3
Carvedilol 2.5
Bisoprolol 1.8
Propranolol 7.2
Sotalol 1.8
Digoxin 7.2
Verapamil 10.8
Diltiazem 24.7
Amiodarone 0.6
Ejection fraction (%, mean ± SD) 63.2±6,3
Coronary artery disease (%) 4.2
SD, Standard deviation
Table 2. Basic electrophysiologic characteristics of the 
study group (n=166)
Basal PR interval (ms, mean ± SD) 155±33
Basal AH interval (ms, mean ± SD) 90.5±33
Basal HV interval (ms, mean ± SD) 43.4±6,3
Tachycardia cycle length (ms, mean±SD) 305±28
Jump presence before ablation (%) 54.2
Atypical AVNRT (%) 4.2
JT presence during ablation (%) 98.8
VA block during ablation (%) 5.4
RF duration (ms, mean ± SD) 123±53
Number of RF (median) 3
Fluoroscopy duration (min, mean ± SD) 52±17
PR duration after ablation (ms, mean±SD) 165±32
Jump after ablation (%) 11.4
Single echo beat after ablation (%) 10.2
Ablation success (%) 98.2
SD, Standard deviation; ms, millisecond; AVNRT, Atrio-
ventricular  nodal  reentrant  tachycardia;  JT,  Junctional 
tachycardia; VA, Ventriculoatrial; RF, radiofrequencyİ. H. Tanboğa et al. Ablation of atrioventricular nodal re-entrant tachycardia 169
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Table 3. The comparison of groups with and without recurrence
Variables Recurrence (-) (n=161) Recurrence (+) (n=5) P value
Age (year, mean ± SD) 48±18 33±14 0.07
Gender (male, %) 31.1 60 0.17
Symptom duration (year, median) 6 6 -
Symptom frequency (number of episodes/month, median) 2 2 -
Hospital type (region, %)  30.4 60 0.15
Basal PR interval (ms, mean ± SD) 155±33 168±20 0.36
Basal AH interval (ms, mean ± SD) 90±33 101±39 0.47
Tachycardia cycle length (ms, mean ± SD) 305±28 292±28 0.32
jump during basal EPS (%) 54.7 60 0.51
Atypical AVNRT (%) 3.1 40 <0.001
RF duration (s, mean ± SD) 122±53 162±44 0.10
Number of RF (median) 4 3 0.78
Fluoroscopy duration (min, mean ± SD) 52±17 55±15 0.73
JT presence during ablation (%) 98.8 100 0.93
VA block during ablation (%) 5.6 0 0.66
Temporary AV block during ablation (%) 3.7 0 0.58
Jump after ablation (%) 11.8 0 0.41
Single echo beat after ablation (%) 10.6 0 0.44
PR duration after ablation (ms, mean ± SD) 166±32 142±27 0.09
SD, Standard deviation, ms, millisecond; EPS: Electrophysiology study; AVNRT, Atrioventricular nodal reentrant tachy-
cardia; JT, Junctional tachycardia; RF, radiofrequency; AV, Atrioventricular; VA, Ventriculoatrial.
younger  and  had  a  higher  atypical AVNRT  rate, 
compared with the patients without recurrence (Ta-
ble 3). As shown in Kaplan-Meier analysis, most 
of the recurrences were observed within the initial 
months. Three of the recurrences occurred during 
the first month, whereas the other 2 occurred within 
the first 3 months (recurrence at 11, 18, 23, 67 and 
88 days, respectively). While there was no differ-
ence between the overall recurrence rates with re-
gard to operator experience and young age, over-
all recurrence rates were found to be statistically 
significantly higher in cases with atypical AVNRT 
(Figure 1). In Cox regression model, univariate un-
corrected hazard ratio (HR) was calculated and by 
using variables with a p value <0.20, multivariate 
HR and p value were calculated. Thus, predictors 
of recurrence during the long-term follow-up after 
AVNRT ablation were found to be young age (<30 
years),  operator  experience  and  atypical AVNRT 
(Table 4).
Table 4. Complication rates of the study group
Complication Rate (n, %)
Death, myocardial infarction, stroke 0
Pulmonary embolism and/or DVT 2 (1.2%)
Cardiac tamponade 0
Pericardial effusion 5 (3%)
Hematoma 5 (3%)
Pseudoaneurysm/ Arteriovenous fistula 1 (0.6%)
Permanent AV block 1 (0.6%)
Temporary AV block 5 (3%)
DVT, Deep vein thrombosis; AV, Atrioventricular.
Overall  recurrence  rate  was  3%  (n=5)  dur-
ing the follow-up period varying between 6 to 40 
months (mean 11 months). Two of the patients di-
agnosed with recurrence were subjected to repeat 
RF ablation, however, the remaining three rejected 
the procedure. The patients with recurrence were İ. H. Tanboğa et al. Ablation of atrioventricular nodal re-entrant tachycardia 170
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Table 5. Univariate and multivariate Cox regression analysis in the estimation of long-term recurrence
Variable Uncorrected HR (95% CI) P value Corrected HR (95% CI) P value
Age 0.95 (0.90 - 1.00) 0.10 0.92 (0.86 - 0.99) 0.03
Gender 0.30 (0.05 - 1.84) 0.19 0.21 (0.02 - 2.00) 0.17
Hospital 1-2 3.3 (0.56 - 20.0) 0.18 20.9 (1.6 - 278) 0.02
Atypical AVNRT 15.4 (2.5 - 92.4) 0.003 17.2 (0.99 - 305) 0.05
RF duration 1.01 (0.99 - 1.04) 0.12 1.01 (0.98 - 1.03) 0.43
PR interval after ablation  0.97 (0.93 - 1.00) 0.11 0.98 (0.93 - 1.02) 0.36
HR, Hazards ratio; CI: Confidence interval; AVNRT, Atrioventricular nodal reentrant tachycardia; RF, radiofrequency
Figure 1. Results of Kaplan-Meier analysis
Major  complication  rate  associated  with 
AVNRT ablation was markedly low. Only 2 patients 
exhibited DVT (both were distal DVT cases). How-
ever, none of the patients demonstrated death, MI, 
stroke  or  cardiac  tamponade.  The  most  common 
minor complications detected by echocardiography 
were asymptomatic minimal/mild pericardial effu-
sion (minimal in 3 patients and mild in 2 patients), 
hematoma  over  the  inguinal  region  requiring  no 
transfusion (n=5), and temporary AV block (n=5, 
lasting for 10 to 15 seconds). AV bock requiring 
pacemaker implantation was occurred only in one 
patient (0.6%).İ. H. Tanboğa et al. Ablation of atrioventricular nodal re-entrant tachycardia 171
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DISCUSSION
The results of this study showed that AVNRT abla-
tion is a safe and effective procedure with regard to 
both acute complications and long-term recurrence. 
RF ablation was successful in 98% of the patients 
without any major complication (death, MI, CEs or 
tamponed). However, AV block requiring permanent 
pacemaker  implantation  was  determined  in  0.6% 
of the patients. The recurrence rate throughout the 
long-term follow-up was 3%. Besides, young age, 
operator experience as well as presence of atypical 
AVNRT were found to be associated with long-term 
recurrence. Moreover, we observed application of 
drugs that have little or no efficacy in the medical 
treatment of supraventricular tachycardia.
RF ablation of the slow pathway has become 
the first choice of treatment in symptomatic AVNRT 
cases resistant to medical therapy.7 It has a high pro-
cedural success rate (>97%) and low recurrence risk 
in long-term follow-up (0.7-5.2%).8-11 In our study, 
the  success  and  recurrence  rates  were  consistent 
with those of the previous studies in the literature. 
The most dreaded complication of AVNRT is AV 
block. Many studies have reported permanent AV 
block rates less than 1%.8,12,13 In our study, we found 
similar rates, as well (0.6%). During the RF abla-
tion procedure, temporary AV blocks are frequently 
encountered (2-24%),14,15 and although majority of 
them  are  of  benign  character,  around  4-5%  may 
result in late permanent AV block.16 In the present 
study, 5 patients exhibited transient AV block (3%), 
however, none of the patients demonstrated a late 
permanent AV block throughout the follow-up pe-
riod.
Recurrence rates during the follow-up period 
after AVNRT ablation are observed to be low (0.7-
5.2%).8-11 Moreover, most of the recurrence cases 
occur within the first days or months.8,17 Similarly, 
in our study, recurrence was observed in 3% of the 
study group and all the recurrences were found to 
occur within the first 3 months. In some studies, re-
sidual slow pathway conduction or single echo beat 
following ablation procedure, have been shown to 
present a risk for long-term recurrence.18-20 How-
ever, contrary to those studies, there are many other 
studies which show that single echo beat or resid-
ual slow pathway conduction do not present a risk 
for recurrence.3,21,23,24 In our study, we determined 
that  residual  slow  pathway  conduction  or  single 
echo beat following ablation did not increase the 
risk of recurrence. In the current study, we deter-
mined young age, operator experience, and atypical 
AVNRT as the predictors of long-term recurrence. 
There  are  two  principal  reasons  why  young  age 
can be a predictor of AVNRT recurrence:1 Young 
patients have a smaller Koch triangle which limits 
the aggression of the operator.25,2 As in the entire 
conduction system, dual nodal conduction is also 
degenerated with increasing age, therefore, damag-
ing of the dual pathways by RF energy, limits the 
maturation of degenerative conduction pathways.8,26 
To  our  knowledge,  ours  is  the  first  study  which 
showed  that  atypical AVNRT  might  be  a  predic-
tor of long-term recurrence. Estner et al. did not 
find  a  relationship  between  atypical AVNRT  and 
recurrence,8 however, Feldman et al. showed that 
atypical AVNRT reduced the success rate of acute 
procedure.25 In another study which evaluated the 
long-term outcomes of 10 atypical AVNRT patients, 
one patient (10%) was found to show recurrence.27 
However,  in  this  study,  comparison  with  typical 
AVNRT was not performed.
In our study, 5 (3%) patients developed peri-
cardial effusion. While 3 of them had minimal effu-
sion, 2 had mild pericardial effusion. However, none 
of the patients demonstrated tamponade. Similar to 
our study, many studies in the literature have found 
the rate of pericardial effusion detectable only by 
echocardiography, showing no clinical significance 
as 1.5-4%. Current low rates of pericardial effusion 
do not support the routine application of echocar-
diography following ablation procedure.28-30
When  the  drugs  used  by  the  patients  before 
presenting to our hospitals were reviewed, most of 
them were observed to be in agreement with the rec-
ommendations of American Heart Association 2003 
Supraventricular Arrhythmia  guideline.  However, 
some patients were found use inappropriate agents 
such as digoxin (7.2%) and sotalol (1.8%). Those 
two agents have very limited efficacy in prophy-
lactic therapy against AVNRT episodes. We believe 
that  treatment  provided  by  specialists  other  than 
cardiologists may be the reason behind inappropri-
ate use of those agents.
In conclusion, catheter ablation of AVNRT is a 
safe and effective procedure, however, several fac-
tors such as young age, operator experience, and 
atypical AVNRT, may have an influence over long-İ. H. Tanboğa et al. Ablation of atrioventricular nodal re-entrant tachycardia 172
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term  arrhythmia  recurrence.  Increasing  operator 
experience and advancing arrhythmia technologies 
may help overcome those limitations.
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